187 related articles for article (PubMed ID: 9714415)
1. Early T-cell apoptosis and Fas expression during antiretroviral therapy in individuals infected with human immunodeficiency virus-1.
Aries SP; Weyrich K; Schaaf B; Hansen F; Dennin RH; Dalhoff K
Scand J Immunol; 1998 Jul; 48(1):86-91. PubMed ID: 9714415
[TBL] [Abstract][Full Text] [Related]
2. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
Dyrhol-Riise AM; Voltersvik P; Røsok BI; Olofsson J; Asjö B
AIDS Res Hum Retroviruses; 2000 Feb; 16(3):191-201. PubMed ID: 10710207
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and the CD95 system in HIV disease: impact of highly active anti-retroviral therapy (HAART).
Gougeon ML; Lecoeur H; Sasaki Y
Immunol Lett; 1999 Mar; 66(1-3):97-103. PubMed ID: 10203040
[TBL] [Abstract][Full Text] [Related]
4. Early changes in peripheral blood T cell subsets induced by antiretroviral treatment of human immunodeficiency virus-1 positive individuals.
Dyrhol-Riise AM; Brantsaeter AB; Dunlop O; Baklien K; Skar AG; Asjö B; Bruun JN; Røsok BI
Scand J Immunol; 2000 Feb; 51(2):195-201. PubMed ID: 10652164
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo.
Sloand EM; Kumar PN; Kim S; Chaudhuri A; Weichold FF; Young NS
Blood; 1999 Aug; 94(3):1021-7. PubMed ID: 10419894
[TBL] [Abstract][Full Text] [Related]
6. Killing of Latently HIV-Infected CD4 T Cells by Autologous CD8 T Cells Is Modulated by Nef.
Sevilya Z; Chorin E; Gal-Garber O; Zelinger E; Turner D; Avidor B; Berke G; Hassin D
Front Immunol; 2018; 9():2068. PubMed ID: 30254642
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy.
Grelli S; Campagna S; Lichtner M; Ricci G; Vella S; Vullo V; Montella F; Di Fabio S; Favalli C; Mastino A; Macchi B
AIDS; 2000 May; 14(8):939-49. PubMed ID: 10853975
[TBL] [Abstract][Full Text] [Related]
8. Combined antiviral therapy reduces HIV-1 plasma load and improves CD4 counts but does not interfere with ongoing lymphocyte apoptosis.
Moretti S; Alesse E; Marcellini S; Di Marzio L; Zazzeroni F; Parroni R; Famularo G; Boschini A; Cifone MG; De Simone C
Immunopharmacol Immunotoxicol; 1999 Nov; 21(4):645-65. PubMed ID: 10584202
[TBL] [Abstract][Full Text] [Related]
9. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Bcl-2, but not of Bax or Bcl-x, is associated with T lymphocyte apoptosis in HIV infection and restored by antiretroviral therapy or by interleukin 2.
Regamey N; Harr T; Battegay M; Erb P
AIDS Res Hum Retroviruses; 1999 Jun; 15(9):803-10. PubMed ID: 10381168
[TBL] [Abstract][Full Text] [Related]
11. Gut Homing CD4+ and CD8+ T-Cell Frequencies in HIV Infected Individuals on Antiretroviral Treatment.
Briceño O; Pinto-Cardoso S; Rodríguez-Bernabe N; Murakami-Ogasawara A; Reyes-Terán G
PLoS One; 2016; 11(11):e0166496. PubMed ID: 27898686
[TBL] [Abstract][Full Text] [Related]
12. Effect of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis: a pilot study.
Moretti S; Alesse E; Di Marzio L; Zazzeroni F; Ruggeri B; Marcellini S; Famularo G; Steinberg SM; Boschini A; Cifone MG; De Simone C
Blood; 1998 May; 91(10):3817-24. PubMed ID: 9573019
[TBL] [Abstract][Full Text] [Related]
13. Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
Benito JM; López M; Martín JC; Lozano S; Martínez P; González-Lahoz J; Soriano V
AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1379-88. PubMed ID: 12487809
[TBL] [Abstract][Full Text] [Related]
14. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
[TBL] [Abstract][Full Text] [Related]
15. Dynamic correlation of apoptosis and immune activation during treatment of HIV infection.
Badley AD; Parato K; Cameron DW; Kravcik S; Phenix BN; Ashby D; Kumar A; Lynch DH; Tschopp J; Angel JB
Cell Death Differ; 1999 May; 6(5):420-32. PubMed ID: 10381636
[TBL] [Abstract][Full Text] [Related]
16. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.
Al-Harthi L; Siegel J; Spritzler J; Pottage J; Agnoli M; Landay A
AIDS; 2000 May; 14(7):761-70. PubMed ID: 10839583
[TBL] [Abstract][Full Text] [Related]
17. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection.
Tilling R; Kinloch S; Goh LE; Cooper D; Perrin L; Lampe F; Zaunders J; Hoen B; Tsoukas C; Andersson J; Janossy G;
AIDS; 2002 Mar; 16(4):589-96. PubMed ID: 11873002
[TBL] [Abstract][Full Text] [Related]
18. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.
Kaufmann GR; Bloch M; Zaunders JJ; Smith D; Cooper DA
AIDS; 2000 May; 14(8):959-69. PubMed ID: 10853977
[TBL] [Abstract][Full Text] [Related]
19. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.
Powles T; Imami N; Nelson M; Gazzard BG; Bower M
AIDS; 2002 Mar; 16(4):531-6. PubMed ID: 11872995
[TBL] [Abstract][Full Text] [Related]
20. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D
Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
